Pf Magazine

Welcome to your go-to source for the newest updates, insights, events, job openings, and advancements in the pharmaceutical sector. Our platform provides you with the tools to stay informed on your schedule. Whether it's through print, online, or social media, we deliver the essential information you need to advance your career.

International

English

Magazine, Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#3382262

United Kingdom

#411101

Health/Biotechnology and Pharmaceuticals

#285

Traffic sources

Monthly visitors

Articles

Lemer Pax and Synapse Medical announce strategic partnership to advance radiation protection technologies in the UK and Ireland - Pf Media

1 week ago | pf-media.co.uk | Emma Cooper

Lemer Pax, a worldwide leader in innovative radiation protection solutions, and Synapse Medical, the Diagnostic Imaging division of Uniphar Medtech, are proud to announce a strategic partnership that will expand the distribution of Lemer Pax’s comprehensive portfolio of medical radiation protection products across the UK, effective from 1st April 2025.
NICE recommends AstraZeneca’s advanced breast cancer treatment

2 weeks ago | pf-media.co.uk | Emma Cooper

The National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s capivasertib (also called Truqap) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer that has certain genetic mutations and has spread.
Maxwellia appoints Alexandra Trehane as Chief Operating Officer

3 weeks ago | pf-media.co.uk | Emma Cooper

Maxwellia, the consumer healthcare company dedicated to widening access to medicines, is pleased to announce the appointment of Alexandra Trehane as Chief Operating Officer (COO). Alexandra brings extensive experience in operations, strategy, and commercial execution. In her new role, she will oversee the company’s day-to-day processes, ensuring continued efficiency and innovation as Maxwellia scales to meet increasing demand for its game-changing over the counter (OTC) medicines.
NICE recommends Takeda’s Hodgkin lymphoma treatment

3 weeks ago | pf-media.co.uk | Emma Cooper

The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine (AVD) to treat adult patients with untreated stage 3 or 4 CD30+ Hodgkin lymphoma (HL), within final draft guidance (FDG)1.
eXmoor Pharma appoints Dr James Miskin as Non-Executive Director

3 weeks ago | pf-media.co.uk | Emma Cooper

Full-service Cell and Gene Therapy (CGT) CDMO eXmoor Pharma has appointed Dr James Miskin as Non-Executive Director following his 23-year tenure at Oxford Biomedica. There, James oversaw delivery of the first-ever commercial batches of lentiviral vectors to manufacture the first FDA-approved CAR-T therapy, which has now been dosed in over 8,000 patients globally.
Positive safety results for Allegro’s injectable osteoarthritis treatment

1 month ago | pf-media.co.uk | Emma Cooper

Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, has found that hydrocelin (ALG-001), its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies conducted for periods of 4 and 13 weeks respectively. The positive results build on hydrocelin’s clean safety profile immediately following treatment, established in previously published preclinical studies.
NHS approves first daily pill for endometriosis

1 month ago | pf-media.co.uk | Emma Cooper

Around 1,000 women per year with endometriosis could benefit from a new treatment that starts working more quickly than injectable alternatives, can be taken at home rather than at clinics, combines all needed hormones in one pill and returns hormone levels to normal faster when stopped.
NHS England is abolished by Prime Minister

1 month ago | pf-media.co.uk | Emma Cooper

Reforms to reduce bureaucracy, make savings and empower NHS staff to deliver better care for patients have been set out by the Prime Minister, Keir Starmer. NHS England will be brought back into the Department of Health and Social Care (DHSC) to put an end to the duplication resulting from two organisations doing the same job in a system currently holding staff back from delivering for patients.
England becomes first country to increase access to oral multiple sclerosis treatment - Pf Media

1 month ago | pf-media.co.uk | Emma Cooper

England is the first country in Europe to provide access to MAVENCLAD® (cladribine tablets) for adults with active relapsing‐remitting multiple sclerosis (RRMS). The National Institute for Health and Care Excellence (NICE) published its Final Draft Guidance (FDG) recommending cladribine tablets as a first-line option for treating RRMS in adults with active disease* when high-efficacy disease-modifying therapies (DMTs) would be considered1.
CordenPharma and Viking Therapeutics enter strategic partnership

1 month ago | pf-media.co.uk | Emma Cooper

CordenPharma, a Contract Development & Manufacturing Organization (CDMO) specialising in the supply of peptide APIs and peptide-based therapeutic finished dosage drug products, has announced the signing of a strategic partnership with Viking Therapeutics, a clinical stage company focused on developing novel therapies for metabolic and endocrine disorders.